Inovio Pharma (INO) Misses Q2 EPS by 119c
Tweet
Share
E-mailGet Alerts INO Hot Sheet
Price: $1.14 +2.70%
EPS Growth %: +60.7%
Financial Fact:
Total operating expenses: 32.74M
Today's EPS Names:
MAYS, CRMT, REPL, More
EPS Growth %: +60.7%
Financial Fact:
Total operating expenses: 32.74M
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
Inovio Pharma (NASDAQ: INO) reported Q2 EPS of ($1.19). Revenue for the quarter came in at $100 thousand.
For earnings history and earnings-related data on Inovio Pharma (INO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
- Sonos partners with Škoda for audio system in new Peaq EV
- Israel said to eye US listing for major defense firms
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
